Enliven Therapeutics, Inc. Common Stock (NASDAQ: ELVN) last traded at $39.49, down 3.31% on the session. The quote above updates while this page is open; the figures below are drawn from Enliven Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Enliven Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ELVN. Its market capitalisation is $2.89 billion.
Valuation measures for Enliven Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.89B |
|---|---|
| Enterprise value | $2.77B |
| Price / book | 3.23 |
| Beta | 1.00 |
Trailing-twelve-month figures tagged in Enliven Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$105.93M |
| EPS (TTM) | -$1.64 |
|---|
| Return on equity | -11.83% |
|---|
| Cash | $135.50M |
|---|
Range and volume for ELVN over the past 52 weeks.
| 52-week high | $62.32 |
|---|---|
| 52-week low | $14.79 |
| Volume | 847.9K |
| Average volume | 1.13M |
| Previous close | $40.84 |
Invest a chosen dollar amount in Enliven Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ELVN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.